These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Gauthier KM; Deeter C; Krishna UM; Reddy YK; Bondlela M; Falck JR; Campbell WB Circ Res; 2002 May; 90(9):1028-36. PubMed ID: 12016270 [TBL] [Abstract][Full Text] [Related]
4. 14,15-epoxyeicosa-5(Z)-enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries. Gauthier KM; Jagadeesh SG; Falck JR; Campbell WB Hypertension; 2003 Oct; 42(4):555-61. PubMed ID: 12953017 [TBL] [Abstract][Full Text] [Related]
5. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Pratt PF; Li P; Hillard CJ; Kurian J; Campbell WB Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1113-21. PubMed ID: 11179054 [TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation. Dimitropoulou C; West L; Field MB; White RE; Reddy LM; Falck JR; Imig JD Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):50-61. PubMed ID: 17259072 [TBL] [Abstract][Full Text] [Related]
7. Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding. Yang W; Holmes BB; Gopal VR; Kishore RV; Sangras B; Yi XY; Falck JR; Campbell WB J Pharmacol Exp Ther; 2007 Jun; 321(3):1023-31. PubMed ID: 17327488 [TBL] [Abstract][Full Text] [Related]
8. 20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site. Chen Y; Falck JR; Tuniki VR; Campbell WB J Pharmacol Exp Ther; 2009 Dec; 331(3):1137-45. PubMed ID: 19762546 [TBL] [Abstract][Full Text] [Related]
9. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries. Gauthier KM; Falck JR; Reddy LM; Campbell WB Pharmacol Res; 2004 Jun; 49(6):515-24. PubMed ID: 15026029 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid. Ye D; Zhou W; Lu T; Jagadeesh SG; Falck JR; Lee HC Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1326-36. PubMed ID: 16537788 [TBL] [Abstract][Full Text] [Related]